Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.

Ghanavatian S, Diep LM, Bárány P, Heimbürger O, Seeberger A, Stenvinkel P, Rohani M, Agewall S.

Angiology. 2014 May;65(5):443-9. doi: 10.1177/0003319713483000. Epub 2013 Apr 7.

PMID:
23567479
2.

Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients.

Banerjee D, Recio-Mayoral A, Chitalia N, Kaski JC.

Clin Cardiol. 2011 Jun;34(6):360-5. doi: 10.1002/clc.20901. Epub 2011 Apr 27.

3.

Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA).

Weiner SD, Ahmed HN, Jin Z, Cushman M, Herrington DM, Nelson JC, Di Tullio MR, Homma S.

Heart. 2014 Jun;100(11):862-6. doi: 10.1136/heartjnl-2013-304893. Epub 2014 Apr 8.

PMID:
24714919
4.

Changes in vascular function and structure in juvenile idiopathic arthritis.

Vlahos AP, Theocharis P, Bechlioulis A, Naka KK, Vakalis K, Papamichael ND, Alfantaki S, Gartzonika K, Mavridis A, Michalis LK, Siamopoulou A.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1736-44. doi: 10.1002/acr.20613.

5.
6.

Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden.

ErŽen B, Šilar M, Šabovič M.

BMC Cardiovasc Disord. 2014 Nov 22;14:166. doi: 10.1186/1471-2261-14-166.

7.

Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease--preliminary data.

Lai S, Mariotti A, Coppola B, Lai C, Aceto P, Dimko M, Galani A, Innico G, Frassetti N, Mangiulli M, Cianci R.

Eur Rev Med Pharmacol Sci. 2014;18(7):1010-7.

8.

Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.

El-Banawy HS, Gaber EW, Maharem DA, Matrawy KA.

J Nephrol. 2012 Jul-Aug;25(4):541-50. doi: 10.5301/jn.5000030.

PMID:
21956768
9.

The relationship between IL-10 levels and cardiovascular events in patients with CKD.

Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1207-16. doi: 10.2215/CJN.08660813. Epub 2014 May 1.

10.

Effects of lower extremity revascularization on the endothelial functions measured with noninvasive brachial artery flow-mediated dilatation.

Unal O, Karatepe O, Ugurlucan M, Koc B, Filizcan U, Aksoy M.

Ann Vasc Surg. 2011 Oct;25(7):969-74. doi: 10.1016/j.avsg.2011.02.013. Epub 2011 May 6.

PMID:
21530156
11.

Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease.

Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M, Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ.

Int Urol Nephrol. 2013 Aug;45(4):1071-8. doi: 10.1007/s11255-012-0354-2. Epub 2012 Dec 15.

PMID:
23242503
12.

Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.

Yilmaz G, Ustundag S, Temizoz O, Sut N, Demir M, Ermis V, Sevinc C, Ustundag A.

Clin Lab. 2015;61(8):1061-70.

PMID:
26427152
13.

[Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1].

Głowińska-Olszewska B, Urban M, Tołwińska J, Peczyńska J, Florys B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):221-7. Polish.

PMID:
16232360
14.
15.

Cardiovascular risk in nonobese hypertensive adolescents: a study based on plasma biomarkers and ultrasonographic assessment of early atherosclerosis.

Głowińska-Olszewska B, Tołwińska J, Łuczyński W, Konstantynowicz J, Bossowski A.

J Hum Hypertens. 2013 Mar;27(3):191-6. doi: 10.1038/jhh.2012.11. Epub 2012 Mar 29.

PMID:
22456501
16.

Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein.

Yasunaga T, Ikeda S, Koga S, Nakata T, Yoshida T, Masuda N, Kohno S, Maemura K.

Int Heart J. 2014;55(2):160-4. Epub 2014 Mar 14.

17.

Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.

Thakur ML, Sharma S, Kumar A, Bhatt SP, Luthra K, Guleria R, Pandey RM, Vikram NK.

Atherosclerosis. 2012 Aug;223(2):507-11. doi: 10.1016/j.atherosclerosis.2012.06.005. Epub 2012 Jun 13.

PMID:
22748277
18.

Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.

Recio-Mayoral A, Banerjee D, Streather C, Kaski JC.

Atherosclerosis. 2011 Jun;216(2):446-51. doi: 10.1016/j.atherosclerosis.2011.02.017. Epub 2011 Feb 18.

PMID:
21414625
19.

Predictors of endothelial dysfunction in patients with rheumatoid arthritis.

Sarli B, Baktir AO, Cebicci M, Dogan Y, Demirbas M, Kurtul S, Saglam H, Akpek M, Sahin O, Arinc H.

Angiology. 2014 Oct;65(9):778-82. doi: 10.1177/0003319713504485. Epub 2013 Sep 26.

PMID:
24078515
20.

Endothelial dysfunction in Buerger's disease and its relation to markers of inflammation.

Joras M, Poredos P, Fras Z.

Eur J Clin Invest. 2006 Jun;36(6):376-82.

PMID:
16684120
Items per page

Supplemental Content

Write to the Help Desk